Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Analysis of BRAF mutation in primary and metastatic melanoma.
Libra M, Malaponte G, Navolanic PM, Gangemi P, Bevelacqua V, Proietti L, Bruni B, Stivala F, Mazzarino MC, Travali S, McCubrey JA. Libra M, et al. Among authors: malaponte g. Cell Cycle. 2005 Oct;4(10):1382-4. doi: 10.4161/cc.4.10.2026. Epub 2005 Oct 13. Cell Cycle. 2005. PMID: 16096377
Detection of BRAF gene mutation in primary choroidal melanoma tissue.
Malaponte G, Libra M, Gangemi P, Bevelacqua V, Mangano K, D'Amico F, Mazzarino MC, Stivala F, McCubrey JA, Travali S. Malaponte G, et al. Cancer Biol Ther. 2006 Feb;5(2):225-7. doi: 10.4161/cbt.5.2.2429. Epub 2006 Feb 20. Cancer Biol Ther. 2006. PMID: 16410717
Melanoma: molecular pathogenesis and emerging target therapies (Review).
Russo AE, Torrisi E, Bevelacqua Y, Perrotta R, Libra M, McCubrey JA, Spandidos DA, Stivala F, Malaponte G. Russo AE, et al. Among authors: malaponte g. Int J Oncol. 2009 Jun;34(6):1481-9. doi: 10.3892/ijo_00000277. Int J Oncol. 2009. PMID: 19424565 Review.
Absence of BRAF gene mutation in non-melanoma skin tumors.
Libra M, Malaponte G, Bevelacqua V, Siciliano R, Castrogiovanni P, Fulvi A, Micali G, Ligresti G, Mazzarino MC, Stivala F, Travali S, McCubrey JA. Libra M, et al. Among authors: malaponte g. Cell Cycle. 2006 May;5(9):968-70. doi: 10.4161/cc.5.9.2724. Epub 2006 May 1. Cell Cycle. 2006. PMID: 16687919
Breast cancer: Molecular basis and therapeutic strategies (Review).
Ligresti G, Libra M, Militello L, Clementi S, Donia M, Imbesi R, Malaponte G, Cappellani A, McCubrey JA, Stivala F. Ligresti G, et al. Among authors: malaponte g. Mol Med Rep. 2008 Jul-Aug;1(4):451-8. Mol Med Rep. 2008. PMID: 21479431
Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response.
McCubrey JA, Steelman LS, Chappell WH, Abrams SL, Montalto G, Cervello M, Nicoletti F, Fagone P, Malaponte G, Mazzarino MC, Candido S, Libra M, Bäsecke J, Mijatovic S, Maksimovic-Ivanic D, Milella M, Tafuri A, Cocco L, Evangelisti C, Chiarini F, Martelli AM. McCubrey JA, et al. Among authors: malaponte g. Oncotarget. 2012 Sep;3(9):954-87. doi: 10.18632/oncotarget.652. Oncotarget. 2012. PMID: 23006971 Free PMC article. Review.
74 results